Filtered By:
Cancer: Breast Cancer

This page shows you your search results in order of relevance. This is page number 10.

Order by Relevance | Date

Total 82776 results found since Jan 2013.

POC Medical raises $21m for portable breast cancer screener
POC Medical Systems said today that it raised $21 million in Series A financing to fund clinical testing and commercialization of its portable breast cancer screening test, MammoAlert. The round was led by BioVentures Investors and also included Sirius America Insurance Company, IFG Healthcare and MIA Investment Limited. The MammoAlert test, which can produce a result in 15 minutes according to the company, uses microfluidics to detect multiple cancer biomarkers in a drop of blood. The system includes a mobile tablet device that stores data in the cloud, where it can be shared with healthcare professionals. The rapid bloo...
Source: Mass Device - January 11, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Diagnostics Funding Roundup Oncology POC Medical Systems Source Type: news

Elucent Medical raises $7.2 in Series A for next-gen breast clip device
Breast cancer-focused medical device startup Elucent Medical has raised $7.2 million in a Series A round of financing, according to an Xconomy report. The funding round for the Eden Prairie, Minn.-based company closed late last year, according to Xconomy, who spoke to co-founder and CEO Laura King. Elucent is developing a more sophisticated version of hook wire equipment for breast cancer procedures, which are currently used to mark areas which will be removed during surgeries. The company’s device would eliminate the need for a metal clip, which are often left in patients long term, and replace it with a small biocompat...
Source: Mass Device - January 23, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Oncology Women's Health Elucent Medical Source Type: news

Dune Medical raises $12m to expand MarginProbe footprint
Dune Medical Devices said today that it raised another $12 million it plans to use to expand the indications for the radiofrequency spectroscopy technology used in its MarginProbe cancer detection device. Alpharetta, Ga.- and Caesarea, Israel-based Dune said the $12.3 million round was led by Canepa Healthcare, ATON Partners and the Kraft Group. Dune said it plans to use the funds to find other cancers the technology, which is designed to provide real-time detection of cancer cells on the margins of tumors. MarginProbe won FDA approval for use in breast lumpectomies in January 2013; today the company said more than 2,500...
Source: Mass Device - July 6, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Funding Roundup Imaging Oncology Wall Street Beat Women's Health Dune Medical Devices Inc. Source Type: news

Task-Based Modeling of a 5k Ultra-High-Resolution Medical Imaging System for Digital Breast Tomosynthesis
High-resolution, low-noise X-ray detectors based on CMOS active pixel sensor (APS) technology have demonstrated superior imaging performance for digital breast tomosynthesis (DBT). This paper presents a task-based model for a high-resolution medical imaging system to evaluate its ability to detect simulated microcalcifications and masses as lesions for breast cancer. A 3-D cascaded system analysis for a 50- $\mu \text{m}$ pixel pitch CMOS APS X-ray detector was integrated with an object task function, a medical imaging display model, and the human eye contrast sensitivity function to calculate the detectability index and a...
Source: IEE Transactions on Medical Imaging - August 31, 2017 Category: Biomedical Engineering Source Type: research

Zebra Medical Vision to host AI1 image analytics on Google Cloud
Israeli machine-learning radiology firm Zebra Medical Vision said it will be uploading its radiology algorithms to the Google (NSDQ:GOOG) Cloud as part of the AI1 automated imaging analytics tools offering it announced last month. The AI1 analytical platform includes a deep learning engine system that can detect various medical findings from image scans on its own, including the detection of liver, lung, cardiovascular and bone disease. The Israel-based company also said said it is planning to introduce new capabilities that would cover breast cancer, lung cancer, brain trauma, hypertension and other clinical areas. Z...
Source: Mass Device - November 8, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Health Information Technology Imaging Zebra Medical Vision Source Type: news

FDA clears Cianna Medical ’ s Savi Scout breast cancer locator for long term implants
Cianna Medical said today that the Savi Scout reflector, part of its system for wire-free breast tumor localization, won FDA clearance as the first non-radioactive implant without a restriction on the length of time that the reflector can remain in a patient’s breast. The new clearance means that doctors can place Scout to mark a biopsy or lumpectomy site and not be constrained by a maximum implant time, the Aliso Viejo, Calif.-based company said. The Scout reflector also won’t interfere with MRI studies, so doctors aren’t restricted in the types of imaging modalities they can use with their patients. The...
Source: Mass Device - November 13, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Food & Drug Administration (FDA) Oncology Regulatory/Compliance Women's Health Cianna Medical Source Type: news

Alpha Tau Medical raises $29m
Alpha Tau Medical said today it raised $29 million in a private funding round to help support its alpha radiation cancer therapy technology. The round was led by Israeli private equity firm Shavit Capital and joined by global equity crowdfunding platform OurCrowd.com and Medison Pharma venture capital arm Medison Ventures, the Israel-based company said. The round was also joined by Apax Partner founds Ronald Cohen and Alan Patricof, Alpha Tau said. “We are confident that Alpha Tau’s ground-breaking technology can be a game changer in the treatment of cancer. Importantly, under the guidance of an experienced m...
Source: Mass Device - September 5, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Funding Roundup Alpha Tau Medical Source Type: news

Seno Medical Instruments touts Imagio breast cancer subtype ID trial results
Seno Medical Instruments today released results from a study of its Imagio opto-acoustc imaging system intended to diagnose breast cancer, touting that both morphologic and functional OA/US features serve as a non-invasive approach to helping distinguish breast cancer molecular subtypes. Results from the study were presented late last month at the Radiological Society of North America’s 2018 annual meeting in Chicago, the San Antonio-based company said. In the study, investigators explored the potential role of functional OA/US imaging-derived hemoglobin de-oxygenation and angiogenesis feature scoring alongside conve...
Source: Mass Device - December 11, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Women's Health Seno Medical Instruments Source Type: news

Elucent Medical wins FDA nod for EnVisio breast surgery navigation device
Elucent Medical said today that it won FDA 510(k) clearance for its EnVisio surgical navigation system. The Eden Prairie, Minn.-based company said that the EnVisio navigation system is designed for use in conjunction with the company’s SmartClip soft tissue marker during breast cancer procedures. The SmartClip soft tissue marker is an alternative to hook-wire localization procedures used to identify malignant tissue for removal, the company said. When used with the Envisio system allows physicians to mark difficult lesions and navigate distances, depths and directions in real-time 3D during breast cancer procedures. ...
Source: Mass Device - April 11, 2019 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Oncology Regulatory/Compliance Surgical Elucent Medical Source Type: news

Tomosynthesis mammographic Imaging Screening Trial (TMIST): An Invitation and Opportunity for the National Medical Association Community to Shape the Future of Precision Screening for Breast Cancer.
Authors: Lee C, McCaskill-Stevens W Abstract To determine the best screening modality for breast cancer, a large randomized clinical trial is underway to compare the mammographic accuracy between the standard digital and tomosynthesis mammography. The Tomosynthesis Mammographic Imaging Screening Trial (TMIST) is also building the world's largest biorepository of breast cancer specimens from all biopsies at screening and wants to ensure it is representative of the US population. We invite the National Medical Association physicians, as leaders in the health care of African Americans, to continue their commitment to ...
Source: Journal of the National Medical Association - July 15, 2020 Category: General Medicine Tags: J Natl Med Assoc Source Type: research

The impact of seven major noncommunicable diseases on direct medical costs, absenteeism, and presenteeism in Gulf Cooperation Council countries
CONCLUSION: The economic burden of noncommunicable diseases in Gulf Cooperation Council countries is substantial, suggesting that successful preventive interventions have the potential to improve both population health and reduce costs. Further research is needed to capture a broader array of noncommunicable diseases and to develop more precise estimates.PMID:34138664 | DOI:10.1080/13696998.2021.1945242
Source: Journal of Medical Economics - June 17, 2021 Category: Health Management Authors: Eric Andrew Finkelstein Jesse D Malkin Drishti Baid Ada Alqunaibet Khaled Mahdi Mohammed Bin Hamad Al-Thani Buthaina Abdulla Bin Belaila Ebrahim Al Nawakhtha Saleh Alqahtani Sameh El-Saharty Christopher H Herbst Source Type: research

Prevalence and determinants of distress among oncology patients at a tertiary care medical city in Riyadh, Saudi Arabia
CONCLUSION: Approximately half of cancer patients were found to have distress. Anxiety, advanced cancer stage, and radiotherapy were independently associated with distress.PMID:34187920 | DOI:10.15537/smj.2021.42.7.20210121
Source: Saudi Medical Journal - June 30, 2021 Category: Middle East Health Authors: Luluh Y Alsughayer Lamees A Altamimi Futoon S Alsaleh Lamya Alsaghan Ibrahim Alfurayh Nashwa M Abdel-Aziz Khalid A Alsaleh Fahad D Alosaimi Source Type: research